METHODS Thirty four patients (mean (SEM) age 62.5 (1.7) years) with angiographically
documented stable CAD, and 36 healthy control subjects (mean (SEM) age 53.6 (2.0) years) …

BACKGROUND: Circulating endothelial progenitor cells (EPCs) may play an important role
in the body's defense against atherosclerosis. Previous studies have shown an association …

The clinical implications of early and late endothelial progenitor cells (EPCs) in coronary
artery disease (CAD) remain unclear. We investigated endothelial dysfunction in CAD by …

Objectives: The objective of this study was to determine whether the number of endothelial
progenitor cells (EPCs) and circulating angiogenic cells (CACs) in peripheral blood was …

We sought to investigate whether numbers and activity of circulating endothelial progenitor
cells (EPCs) correlate with severity of coronary stenosis as well as cardiovascular risk …

The pathophysiology of coronary artery disease (CAD) progression is not well understood.
Endothelial progenitor cells (EPCs) may have an important role. In the present observational …

Background: The association between endothelial progenitor cells (EPCs) at the time of
percutaneous coronary intervention (PCI) and the subsequent long-term clinical outcome …

Background Circulating endothelial progenitor cells (EPCs) play a role in the repair and
regeneration of the endothelium and may represent a novel cardiovascular risk factor. South …

Objectives: We prospectively investigated the relationship of circulating endothelial
progenitor cells at time of percutaneous coronary intervention to the subsequent …

Recent studies provide increasing evidence that postnatal neovascularization involves bone
marrow–derived circulating endothelial progenitor cells (EPCs). The regulation of EPCs in …